Kiniksa Pharmaceuticals International, plc KNSA
Set alert
90.80 USD -1.44 -1.56%
At close · Nov 2
91.50 +0.70 +0.77%
After hours · Nov 2, 4:44 PM ET
90.56 Day range 94.14
37.01 52-week range 97.56
- YTD
- +120.12%
- 1 year
- +145.34%
- Open
- 92.83
- Prev close
- 92.24
- Mkt cap
- 7.13B
- Vol
- 998.88K
- Avg vol
- 625.02K
- EPS
- 1.30
- P/E
- 69.85
- Div yield
- 0.00%
More statistics
- Low
- 90.56
- High
- 94.14
- Forward P/E
- 41.60
- Beta
- 0.08
- Short ratio
- 6.53
- Inst. own
- 101.31%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2027
- 50-d avg
- 79.16
- 200-d avg
- 60.21
- 1y target
- 109.43
5D chart
Events in this range
- Oct 27, 2026Earnings: 0.56; estimate 0.371; surprise 50.94%
- Oct 28, 2026Rating: Wells Fargo · Overweight → Overweight
- Oct 28, 2026Rating: Wedbush · Outperform → Outperform
- Oct 28, 2026Rating: Goldman Sachs · Buy → Buy
- Oct 30, 2026Rating: JP Morgan · Overweight → Overweight
Signals (150)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:10 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 3:10 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 3:10 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 3:05 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 3:00 PM | 12 hours ago |
| SMA: Bullish | Nov 2, 2:55 PM | 12 hours ago |
| SMA: Bearish | Nov 2, 2:45 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 2:10 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 2:00 PM | 13 hours ago |
| SMA: Bullish | Nov 2, 1:55 PM | 13 hours ago |
| MACD: Buy Signal | Nov 2, 1:55 PM | 13 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 1:40 PM | 14 hours ago |
| MACD: Sell Signal | Nov 2, 1:40 PM | 14 hours ago |
| SMA: Bullish | Nov 2, 1:05 PM | 14 hours ago |
| SMA: Bullish | Nov 2, 1:05 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 1:00 PM | 14 hours ago |
| SMA: Bearish | Nov 2, 1:00 PM | 14 hours ago |
Newest 20 of 150.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 109.43 +20.5% upside
Now 90.80
- Target (low)
- 98.00
- Target (mean)
- 109.43
- Target (high)
- 134.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.275 | 0.14 – 0.41 | 0.17 | +61.8% | 306.56M | +51.7% | 4 |
| Next quarter | 0.44 | 0.29 – 0.55 | 0.27 | +63.0% | 313.78M | +46.4% | 4 |
| Current year | 1.50 | 1.22 – 1.91 | 0.75 | +99.3% | 1.05B | +55.0% | 4 |
| Next year | 2.18 | 1.59 – 2.80 | 1.50 | +46.0% | 1.32B | +26.2% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 28, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Oct 28, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Oct 28, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 30, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 29, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jul 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jul 29, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Jul 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 23, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jul 13, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Jun 29, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Apr 29, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 29, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Apr 29, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 28, 2026 | Jefferies | Maintained | Buy | Buy |
| Apr 16, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Feb 25, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Feb 25, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Feb 19, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Jan 13, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Oct 29, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Oct 17, 2025 | Citigroup | Maintained | Buy | Buy |
| Oct 13, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Sep 29, 2025 | TD Cowen | Initiated | — | Buy |
| Sep 25, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Jul 29, 2025 | Jefferies | Maintained | Buy | Buy |
| Jul 9, 2025 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 29, 2025 | Jefferies | Maintained | Buy | Buy |